Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
Clinical trial NCT00984464 · COMPLETED
Trial details
- NCT number
- NCT00984464
- Sponsor
- Oncolytics Biotech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2014-02-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.